BioCentury
ARTICLE | Finance

Betting on biosimilars

Bio-banker joins Coherus to build on top of Daiichi biosimilars deal

November 12, 2012 8:00 AM UTC

George Montgomery joined biosimilars company Coherus Biosciences Inc. as CFO after having spent much of the last 25 years in San Francisco's financial district.

Coherus came out of stealth mode in May when it announced a partnership with Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568) to develop and commercialize biosimilars of autoimmune drugs etanercept and rituximab in Asia...